| 1088 |
decreased |
decreased neurotransmitter release
(MP:0003990)
|
CNS neuron (sensu Vertebrata)
(CL:0000117)
|
1944: Synaptic dysfunction
|
| 1090 |
decreased |
response to odorant
(GO:1990834)
|
Nose
(FMA:46472)
|
2317: Loss of olfactory function
|
| 1093 |
decreased |
androgen receptor signaling pathway
(GO:0030521)
|
androgen receptor
(PR:000004191)
|
None
|
| 1094 |
decreased |
ovarian follicle development
(GO:0001541)
|
granulosa cell
(CL:0000501)
|
1800: Granulosa cell proliferation of gonadotropin-independent follicles, Reduced
|
| 1097 |
decreased |
Dementia
(HP:0000726)
|
drebrin
(PR:000006296)
|
2242: Abnormality, dendritic spine morphology
|
| 1098 |
decreased |
long term synaptic depression
(GO:0060292)
|
drebrin
(PR:000006296)
|
2242: Abnormality, dendritic spine morphology
|
| 1101 |
decreased |
dendritic spine morphogenesis
(GO:0060997)
|
actin cytoskeleton
(GO:0015629)
|
2078: Loss of drebrin
|
| 1110 |
decreased |
cellular response to oxidative stress
(GO:0034599)
|
|
1869: Diminished protective oxidative stress response
|
| 1113 |
decreased |
G-protein coupled receptor signaling pathway
(GO:0007186)
|
alpha-1A adrenergic receptor
(PR:000001183)
|
2370: Agonism binding, α1-Adrenoreceptor
|
| 1115 |
decreased |
Decreased activity of mitochondrial complex III
(HP:0011924)
|
mitochondrial respiratory chain complex III
(GO:0005750)
|
1542: Inhibition, Mitochondrial complex III
|
| 1117 |
decreased |
Decreased circulating gonadotropin level
(HP:0030339)
|
circulatory system
(UBERON:0001009)
|
1986: Decreased, Gonadotropins
|
| 1120 |
decreased |
neurotransmitter secretion
(GO:0007269)
|
Metastin
(CHEBI:80304)
|
968: Decreased, release of kisspeptin from anteroventral periventricular nucleus (AVPV) neurons
|
| 1123 |
decreased |
regulation of vascular permeability
(GO:0043114)
|
|
None
|
| 1125 |
decreased |
mRNA transcription
(GO:0009299)
|
undifferentiated genital tubercle
(UBERON:0005876)
|
None
|
| 1126 |
decreased |
protein import into nucleus, translocation
(GO:0000060)
|
androgen receptor
(PR:000004191)
|
2393: Androgen receptor nuclear transcriptional activity in genital-tubercle tissues, reduced
|
| 1127 |
decreased |
regulation of DNA binding
(GO:0051101)
|
androgen
(CHEBI:50113)
|
2393: Androgen receptor nuclear transcriptional activity in genital-tubercle tissues, reduced
|
| 1128 |
decreased |
mesenchymal-epithelial cell signaling
(GO:0060638)
|
fibroblast growth factor receptor 2
(PR:000001449)
|
2399: Fibroblast growth factor 10, fibroblast growth factor receptor 2 isoform IIIb signaling in genital tissue, reduced
|
| 1129 |
decreased |
mesenchymal-epithelial cell signaling
(GO:0060638)
|
fibroblast growth factor 10
(PR:000007480)
|
2399: Fibroblast growth factor 10, fibroblast growth factor receptor 2 isoform IIIb signaling in genital tissue, reduced
|
| 1130 |
decreased |
|
fibroblast growth factor 10
(PR:000007480)
|
2399: Fibroblast growth factor 10, fibroblast growth factor receptor 2 isoform IIIb signaling in genital tissue, reduced
|
| 1131 |
decreased |
|
fibroblast growth factor 2
(PR:000007489)
|
None
|
| 1132 |
decreased |
cell activation
(GO:0001775)
|
fibroblast growth factor 2
(PR:000007489)
|
2399: Fibroblast growth factor 10, fibroblast growth factor receptor 2 isoform IIIb signaling in genital tissue, reduced
|
| 1136 |
decreased |
neuropeptide signaling pathway
(GO:0007218)
|
Metastin
(CHEBI:80304)
|
None
|
| 98 |
arrested |
developmental process
(GO:0032502)
|
male reproductive organ
(UBERON:0003135)
|
240: Feminisation or incomplete development, Primary and accessory male sex organs
|
| 1092 |
arrested |
androgen receptor signaling pathway
(GO:0030521)
|
androgen receptor
(PR:000004191)
|
None
|
| 1135 |
arrested |
delayed balanopreputial separation
(MP:0008940)
|
prepuce of penis
(UBERON:0001332)
|
2401: Male preputial separation, failed/delayed
|